APDN - adnas.com Profit before interest, taxes and amortization
Applied DNA Sciences (APDN) utilizes its proprietary LinearRx facility in New York to ensure large-scale DNA synthesis under strict biocontrol. EBITDA reflects the dynamics of these capacities, where marks a new level. LinearDNA technology accelerates chain replication, positioning the company as a critical partner for gene therapy, although tight biotech R&D budgets limit opportunities to increase contract pricing.
Summary analytical data breakdowns for Applied DNA Sciences, Inc. (APDN)
- stock value and consensus price forecast:
- market capitalization statistics:
- book capitalization data:
- business debt structure and liquidity details:
Debt to Equity Ratio Applied DNA Sciences|APDN - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Applied DNA Sciences Inc|APDN - Company Aggregate Debts|Debts to Book Capitalization Applied DNA Sciences|APDN - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Applied DNA Sciences|Interim Coverage Ratio adnas.com
- earnings and valuation multiples indicators:
APDN - Net Profit|Future Profit Applied DNA Sciences|APDN - P/E Multiple|Market Cap to Projected Earnings adnas.com|APDN - PEG Multiple|Company Value to EBITDA Applied DNA Sciences|APDN - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Applied DNA Sciences|APDN - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months adnas.com|APDN - Earnings growth in current year|Expected net earnings per share growth next year Applied DNA Sciences
Summary company analytics:APDN (Applied DNA Corp)
The scaling of molecular control systems to combat counterfeiting is directly reflected in the absolute operating profit, which measures net cash flow from core operations before depreciation and taxes. This chart allows for an assessment of the effectiveness of Applied DNA Sciences (APDN) strategic partnerships with the public sector, revealing the business's actual ability to act as a cash generator and confirming the asset's fundamental stability.
Competitor analysis for Applied DNA Sciences
Operating income before deduction of amortization Tempus (TEM)|Qiagen N.V. - Operating profit EBITDA|Profit before interest, taxes and amortization ionispharma.com|RGEN: Operating profit EBITDA|Operating profit before amortization RNA|Operating profit before deduction of amortization CRSP|WGS: Income before deduction of interest, taxes and amortization|Operating profit EBITDA RARE|beamtx.com - Operating profit before amortization|Profit before payment of interest, taxes and amortization Sarepta SRPT|TWST: Operating profit before amortization|10x Genomics Corp - Operating profit EBITDA|NTLA - Operating profit EBITDA|STOK (Stoke Therapeutics) - Operating profit before deduction of amortization|biolifesolutions.com - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Wave Life Sciences Ltd.|Maze Therapeutics, Inc. (MAZE) - Operating income before deduction of amortization|Operating profit EBITDA SION|Operating profit before deduction of amortization Prime Medicine Bio PRME|Operating profit EBITDA TSHA (Taysha Gene Therapies)|Operating income before deduction of amortization uniqure.com (QURE)|MeiraGTx - Operating profit EBITDA|Profit before interest, taxes and amortization REGENXBIO Inc|Solid Bio (SLDB) - Profit before payment of interest, taxes and amortization|Operating profit before amortization OCGN|PACB (Pacific Biosciences) - Operating profit EBITDA|Operating profit before deduction of amortization benitec.com (BNTC)|Operating profit EBITDA DSGN|RCKT - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization 4D Molecular Therapeutics Inc FDMT|Operating income before deduction of amortization Lexeo Therapeutics Inc. (LXEO)|Korro Bio, Inc - Operating profit EBITDA|EDIT - Operating profit EBITDA|Silence Therapeutics plc (SLN) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization PRQR (ProQR Therapeutics)|CDXS (Codexis Inc) - Operating profit EBITDA|Operating profit before amortization SGMO (Sangamo BioSciences)|Profit before payment of interest, taxes and amortization Nautilus Biotechnology (NAUT)|metagenomi.co - Operating profit before amortization|Operating profit EBITDA DTIL (Precision BioSciences, Inc.)|GBIO: Operating profit before amortization|BOLD - Profit before payment of interest, taxes and amortization|XCUR (Exicure, Inc.) - Operating profit before amortization|IMNN: Operating profit EBITDA|Phio Pharmaceuticals Corp. (PHIO) - Operating profit EBITDA|MBIO (Mustang Bio Inc) - Operating profit EBITDA|Operating profit EBITDA TransCode|Profit before payment of interest, taxes and amortization Bionano Genomics, Inc. (BNGO)|BLUE: Profit before deduction of interest, taxes, depreciation and amortization|Profit before payment of interest, taxes and amortization ImmunoPrecise Antibodies Ltd. IPA|OMGA (omegatherapeutics.com) - Profit before deduction of interest, taxes, depreciation and amortization|OMIC - Profit before payment of interest, taxes and amortization|RGLS: Profit before payment of interest, taxes and amortization|SYRS: Operating profit EBITDA|TBIO - Operating income before deduction of amortization|TCON (TRACON Pharmaceuticals) - Operating profit EBITDA|Profit before interest, taxes and amortization unitybiotechnology.com UBX
